Retractable Technologies (RVP) Stock Price
Retractable Technologies Price
Over the last 19 years Retractable Technologies grew revenue by 2.2% annually, reaching 38.27 M USD. Earnings per share have grown at 4.5% per year over the last 12 years. For Retractable Technologies, the net margin of -32.8% is down versus 29.8% a few years ago. At today's price the dividend yield works out to roughly 17.59%. The payout ratio is around 83% of earnings. The stock trades about 15% above its 52-week low.
Retractable Technologies stock price
Details
Stock Price
ⓘHow to Read This Chart
This chart tracks the historical stock price of Retractable Technologies over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.
Total Return vs. Price Return
The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.
Intraday Price Data
When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Retractable Technologies stock reacts to market openings, earnings releases, or breaking news throughout the trading session.
What to Look For
Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Retractable Technologies's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.
| Date | Retractable Technologies Price |
|---|---|
| 9/4/2026 | 0.71 USD |
| 9/3/2026 | 0.71 USD |
| 9/2/2026 | 0.72 USD |
| 9/1/2026 | 0.72 USD |
| 8/31/2026 | 0.73 USD |
| 8/28/2026 | 0.72 USD |
| 8/27/2026 | 0.72 USD |
| 8/26/2026 | 0.73 USD |
| 8/25/2026 | 0.73 USD |
| 8/24/2026 | 0.71 USD |
| 8/21/2026 | 0.73 USD |
| 8/20/2026 | 0.73 USD |
| 8/19/2026 | 0.73 USD |
| 8/18/2026 | 0.70 USD |
| 8/17/2026 | 0.70 USD |
| 8/14/2026 | 0.69 USD |
| 8/13/2026 | 0.68 USD |
| 8/12/2026 | 0.67 USD |
| 8/11/2026 | 0.68 USD |
| 8/10/2026 | 0.67 USD |
| 8/7/2026 | 0.67 USD |
| 8/6/2026 | 0.68 USD |
| 8/5/2026 | 0.68 USD |
| 8/4/2026 | 0.68 USD |
| 8/3/2026 | 0.66 USD |
| 7/31/2026 | 0.66 USD |
| 7/30/2026 | 0.67 USD |
| 7/29/2026 | 0.67 USD |
| 7/27/2026 | 0.68 USD |
| 7/23/2026 | 0.68 USD |
Retractable Technologies Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Details
Retractable Technologies Income Statement, Balance Sheet, Cash Flow Statement
| REVENUEM USD |
|---|
| REVENUE GROWTH% |
| GROSS MARGIN% |
| GROSS INCOMEM USD |
| EBITM USD |
| EBIT MARGIN% |
| NET INCOMEM USD |
| NET INCOME GROWTH% |
| SHARESM |
| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 36.00 | 32.00 | 33.00 | 30.00 | 34.00 | 29.00 | 29.00 | 34.00 | 33.00 | 41.00 | 81.00 | 188.00 | 94.00 | 43.00 | 33.00 | 38.00 |
| -5.26 | -11.11 | 3.13 | -9.09 | 13.33 | -14.71 | – | 17.24 | -2.94 | 24.24 | 97.56 | 132.10 | -50.00 | -54.26 | -23.26 | 15.15 |
| 33.33 | 31.25 | 33.33 | 33.33 | 35.29 | 34.48 | 34.48 | 26.47 | 30.30 | 34.15 | 45.68 | 50.53 | 29.79 | 20.93 | -3.03 | -2.63 |
| 12.00 | 10.00 | 11.00 | 10.00 | 12.00 | 10.00 | 10.00 | 9.00 | 10.00 | 14.00 | 37.00 | 95.00 | 28.00 | 9.00 | -1.00 | -1.00 |
| -6.00 | -4.00 | -3.00 | -5.00 | -2.00 | -3.00 | -3.00 | -3.00 | -1.00 | 2.00 | 24.00 | 72.00 | 5.00 | -11.00 | -21.00 | -20.00 |
| -16.67 | -12.50 | -9.09 | -16.67 | -5.88 | -10.34 | -10.34 | -8.82 | -3.03 | 4.88 | 29.63 | 38.30 | 5.32 | -25.58 | -63.64 | -52.63 |
| 2.00 | 1.00 | -4.00 | -6.00 | -2.00 | 4.00 | -3.00 | -3.00 | -1.00 | 3.00 | 24.00 | 56.00 | 5.00 | -7.00 | -11.00 | -12.00 |
| -122.22 | -50.00 | -500.00 | 50.00 | -66.67 | -300.00 | -175.00 | – | -66.67 | -400.00 | 700.00 | 133.33 | -91.07 | -240.00 | 57.14 | 9.09 |
| 23.99 | 25.32 | 27.24 | 27.26 | 27.66 | 28.62 | 31.33 | 32.67 | 32.67 | 32.68 | 33.37 | 34.26 | 29.94 | 29.94 | 29.94 | 29.94 |
Details
Income Statement Key Figures
ⓘRevenue and Revenue Growth
Revenue is the starting point of every income statement — it measures the total sales Retractable Technologies generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.
Gross Margin
Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Retractable Technologies retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Retractable Technologies's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.
EBIT and EBIT Margin
EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.
Net Income and Earnings Per Share (EPS)
Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.
Shares Outstanding
The total number of shares Retractable Technologies has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.
Analyst Estimates
The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Retractable Technologies's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.
Retractable Technologies stock margins
3 Years
5 Years
10 Years
25 Years
Max
Details
Retractable Technologies Stock Revenue, EBIT, Earnings per Share
3 Years
5 Years
10 Years
25 Years
Max
Details
Retractable Technologies business model & stock analysis
Retractable Technologies SWOT Analysis
Strengths
Retractable Technologies Inc (RTI) has several key strengths:
- Strong patent portfolio: RTI owns a vast portfolio of patents, providing a competitive advantage and protecting its innovative retractable needle technology.
- Quality products: The company is known for manufacturing high-quality medical devices, ensuring safety and reliability for healthcare professionals and patients.
- Market leadership: RTI is a market leader in the development and production of retractable needle technology, giving it a significant market share and positioning it as a trusted brand in the healthcare industry.
- Strong distribution network: The company has established strategic partnerships with distributors globally, enabling efficient and widespread distribution of its products.
Weaknesses
Although RTI has various strengths, it also faces some weaknesses:
- Dependency on a limited product line: RTI primarily focuses on retractable needle technology, which can limit its product diversification and potentially expose the company to market fluctuations.
- Competition: The medical device industry is highly competitive, and RTI faces competition from other manufacturers who offer similar retractable needle products.
- Limited marketing budget: Compared to some larger competitors, RTI may have a relatively smaller marketing budget, which could impact its ability to effectively promote its products.
Opportunities
RTI can leverage the following opportunities to drive growth:
- Increasing demand for safety features: As awareness about needlestick injuries and bloodborne diseases grows, there is a rising demand for retractable needle devices, presenting an opportunity for RTI to expand its customer base.
- Emerging markets: RTI can explore untapped markets in developing countries, where healthcare infrastructure is expanding, and demand for quality medical devices is on the rise.
- Technological advancements: The company can invest in research and development efforts to enhance its retractable needle technology further, potentially gaining a competitive edge through improved product performance and features.
Threats
RTI should be cautious of the following potential threats:
- Regulatory challenges: The medical device industry is subject to stringent regulations, and changes in regulations or compliance requirements could impact RTI's ability to market and sell its products.
- Intense competition: Competitors could develop similar or superior retractable needle technology, challenging RTI's market position and potentially leading to a loss of market share.
- Economic factors: Economic downturns or fluctuations in healthcare budgets could affect the purchasing power of healthcare providers, potentially reducing demand for RTI's products.
Retractable Technologies Employees
3 Years
5 Years
10 Years
25 Years
Max
Details
Retractable Technologies Eulerpool Fair Value
Details
Fair Value Estimate
ⓘWhat Is Fair Value?
Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.
Earnings-Based Fair Value
Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.
Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021
Revenue-Based Fair Value
Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"
Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021
Dividend-Based Fair Value
Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.
Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021
How to Use This Chart
When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.
Retractable Technologies historical P/E ratio, EBIT multiple, and P/S ratio
Retractable Technologies annual returns
Details
Annual Return
ⓘWhat This Chart Shows
This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.
Price Return
Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.
Dividend Return
Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.
What to Look For
Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.
Retractable Technologies shares outstanding
3 Years
5 Years
10 Years
25 Years
Max
Details
Retractable Technologies Dividend History
1 years of dividend payments
Retractable Technologies dividend payout ratio
3 Years
5 Years
10 Years
25 Years
Max
Details
EESG©
Eulerpool ESG Scorecard© for the Retractable Technologies stock
EEnvironment
20
Environment
SSocial
20
Social
GGovernance (Corporate Governance)
4
Governance (Corporate Governance)
The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.
Retractable Technologies shareholder structure
| % | Name |
|---|---|
1.94301% | |
1.94028% | |
1.47431% | |
0.80535% | |
0.40416% | |
0.29573% |
Retractable Technologies Beneficial Ownership Filings (SEC 13D/G)
Retractable Technologies Executives and Management Board
7 members · avg. age 63 · 29 % women
Mr. Thomas Shaw (74)
Chairman of the Board, President, Chief Executive Officer, Founder
1.19 M USD
Management
Ms. Michele Larios (58)
Vice President, General Counsel, Secretary
Mr. John Fort (56)
Chief Financial Officer, Vice President, Treasurer, Director · since 2019
Board of Directors
Mr. Marco Laterza (77)
Independent Director
Mr. Walter Bigby (60)
Independent Director
Mr. Darren Findley (61)
Independent Director
Ms. Amy Mack (57)
Independent Director
Retractable Technologies Supply Chain
Frequently asked questions about Retractable Technologies
Retractable Technologies Inc operates under the business model of manufacturing and marketing safety medical devices. As a company, it specializes in retractable syringes, blood collection devices, and other medical products to prevent accidental needlestick injuries. Retractable Technologies Inc prioritizes safety and aims to provide healthcare professionals with innovative tools that minimize the risk of needle-related injuries. With its extensive product portfolio and focus on safety, Retractable Technologies Inc continues to contribute to the medical industry by promoting a safer and more efficient healthcare environment.
Retractable Technologies Inc is primarily active in the healthcare industry.
The main competitors of Retractable Technologies Inc in the market include Becton, Dickinson and Company (BD), B. Braun Melsungen AG, Cardinal Health Inc., and Terumo Corporation. These companies operate in the medical devices industry and offer various products including safety syringes, IV catheters, and other medical supplies. Retractable Technologies Inc faces competition from these established players in terms of product quality, pricing, market share, and customer reach. However, Retractable Technologies Inc distinguishes itself through its patented retractable needle technology, providing enhanced safety and usability features for healthcare professionals.
Retractable Technologies Inc, based in Little Elm, Texas, is a leading manufacturer of safety medical devices, specializing in retractable needle technologies. Founded in 1994 by Thomas J. Shaw, the company initially focused on developing and commercializing their patented VanishPoint® blood collection tube holder. This innovative product aimed to minimize the risk of needlestick injuries among healthcare professionals. Over the years, Retractable Technologies Inc has expanded its product portfolio to include a wide range of safety medical devices, including retractable syringes and safety IV catheters. With a strong commitment to patient and healthcare worker safety, Retractable Technologies Inc continues to be a trusted industry leader in the field.
Retractable Technologies Inc has achieved significant milestones throughout its history. Some noteworthy achievements include the development and patenting of innovative safety medical products, such as the VanishPoint® blood collection tube holder. The company has also obtained various FDA clearances for its devices, positioning it as a leading player in the healthcare industry. Furthermore, Retractable Technologies Inc has successfully established strategic partnerships and collaborations with key market players, enhancing its market presence and expanding its customer base. These milestones demonstrate the company's commitment to creating cutting-edge medical devices and its dedication to improving patient safety.
Retractable Technologies Inc is primarily present in the United States. With headquarters in Little Elm, Texas, the company focuses on the domestic market. Their innovative medical devices, such as safety syringes and blood collection sets, are widely used by healthcare professionals across the country. Retractable Technologies Inc has built a strong presence and reputation within the United States for its cutting-edge products that prioritize safety and ease of use.
Retractable Technologies Inc represents a strong commitment to safety and innovation in the healthcare industry. With a focus on developing safe medical devices, Retractable Technologies is dedicated to preventing needlestick injuries and other related accidents. Their corporate philosophy is centered around providing high-quality, reliable products that enhance patient and healthcare professional safety. By prioritizing research and development, Retractable Technologies continuously strives to improve their products and meet the evolving needs of the healthcare community. Through their dedication to safety and innovation, Retractable Technologies Inc has become a trusted name in the medical device industry.
Converted at the current exchange rate, the Retractable Technologies share trades at 0.61 EUR (0.71 USD).
Retractable Technologies Inc. (RTI) is a leading company in the global production of medical syringes and needles. The US-based company is headquartered in Little Elm, Texas and has been listed on NASDAQ since 1994. RTI manufactures disposable medical syringes and needles that ensure a high level of safety and sterility. The portfolio includes disposable syringes, withdrawal needles, safety needles, and catheters. The company has received several patents for its products, including the attached pull cord that facilitates needle insertion while reducing the oxidation process of syringes. RTI's business model is based on three pillars: production, research, and development of new products. The company focuses on ensuring the highest quality and sterility, as well as creating products that help hospitals and clinics provide safer care for their patients. The core business of RTI is the production of medical syringes and needles. The company has eight production facilities in the US and employs over 700 people worldwide. The production of syringes and needles is a highly technical process that requires the highest quality and precision. Therefore, the company continually invests in state-of-the-art production and quality assurance technology. The second focus of RTI is research and development of new products. The company has a dedicated team of scientists and engineers working on the development of new technologies. An important focus is improving the safety of medical syringes and needles and developing products that make the work of healthcare professionals safer and more effective. RTI is also active in other areas. For example, the company has a subsidiary, Inverness Medical Innovations, which specializes in the production of rapid tests for healthcare. The rapid tests allow for quick diagnosis of diseases and effective treatment. In summary, RTI is a leading company in the production of medical syringes and needles with a clear focus on quality, safety, and innovation. The company has a strong presence in the US and exports its products worldwide. The company's research and development department is dedicated to developing new products and technologies that improve the lives of medical professionals and make patient care safer.
The revenue cannot currently be calculated for Retractable Technologies.
The profit cannot currently be calculated for Retractable Technologies.
The P/E ratio cannot be calculated for Retractable Technologies at the moment.
The P/S cannot be calculated for Retractable Technologies currently.
The Eulerpool Quality Score for Retractable Technologies is 1/10.
The ISIN of Retractable Technologies is US76129W1053. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Retractable Technologies is 785356. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Retractable Technologies is RVP. The ticker symbol is used to trade Retractable Technologies shares on the stock exchange.
The current dividend yield of Retractable Technologies is 17.59 %.
Retractable Technologies paid dividends every year for the past 0 years.
Retractable Technologies is assigned to the 'Health' sector.
To receive the latest dividend of Retractable Technologies from amounting to 0.13 USD, you needed to have the stock in your portfolio before the ex-date on .
The last dividend was paid out on .
The dividends of Retractable Technologies are distributed in USD.
Retractable Technologies stock
Retractable Technologies Peer Group
Retractable Technologies Ticker
Retractable Technologies FIGI
All fundamentals and in-depth analysis of Retractable Technologies
Our stock analysis for Retractable Technologies stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Retractable Technologies. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.